m+Medelevator.RU
← Поиск публикаций
Neurophotonics · 2025

Cerebrovascular alterations in a mouse model of late-onset Alzheimer's disease.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Crouzet Christian, Xie Danny F, Laquindanum Nuqui Maiella Nona, Hasselman Jonathan, Phan Thinh, Wilson Robert H, Baglietto-Vargas David, Da Cunha Celia, Davtyan Hayk, Forner Stefania, Jullienne Amandine, Bazrafkan Afsheen, LaFerla Frank M, Obenaus Andre, Blurton-Jones Mathew, Akbari Yama, Green Kim N, Choi Bernard

Аннотация

SIGNIFICANCE: Alzheimer's disease (AD) is an age-related neurodegenerative disorder with cerebrovascular alterations contributing to cognitive decline. Assessing cerebrovascular changes in mouse models that mimic the human condition of late-onset, sporadic AD is important for better human applicability.

AIM: To assess cerebrovascular changes in three mouse models: (1) 3xTg-AD; (2) the humanized amyloid-beta knock-in ( hA β -KI) mouse model of late-onset, sporadic AD; and (3) age-matched wild-type mice.

APPROACH: We measured resting-state cerebral blood flow (CBF) and neurovascular coupling (NVC) using laser speckle imaging (LSI) and performed ex vivo analyses of gene expression and cerebrovascular structure using bulk ribonucleic acid sequencing and confocal microscopy, respectively.

RESULTS: Our study identifies specific cerebrovascular alterations in the hA β -KI mouse model, including increased resting-state CBF, a shift toward smaller blood vessel diameters, impaired NVC, and transcriptomic changes related to metabolism and inflammation. Notably, we found that the increased resting-state CBF was primarily associated with female hA β -KI mice.

CONCLUSIONS: Our findings demonstrate that the hA β -KI mouse model exhibits cerebrovascular alterations that warrant further investigation to uncover the underlying mechanisms. Expanding these studies could enhance our understanding of cerebrovascular alterations in AD and support the development of targeted therapeutic strategies.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты